194 related articles for article (PubMed ID: 26032616)
1. Office-based laryngeal injection of botulinum toxin for paradoxical vocal fold motion in a child.
Montojo J; González R; Hernández E; Zafra M; Plaza G
Int J Pediatr Otorhinolaryngol; 2015 Jul; 79(7):1161-3. PubMed ID: 26032616
[TBL] [Abstract][Full Text] [Related]
2. Periodic botulinum toxin injections for paradoxical vocal fold motion in a child with cerebral palsy: a case study.
Cheng YS; Bhutta MF; Ramsden JD; Lennox P
Int J Pediatr Otorhinolaryngol; 2014 Mar; 78(3):570-1. PubMed ID: 24485974
[TBL] [Abstract][Full Text] [Related]
3. Vocal fold botulinum toxin injection for refractory paradoxical vocal fold motion disorder.
deSilva B; Crenshaw D; Matrka L; Forrest LA
Laryngoscope; 2019 Apr; 129(4):808-811. PubMed ID: 30548857
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin treatment of false vocal folds in adductor spasmodic dysphonia: Functional outcomes.
Simpson CB; Lee CT; Hatcher JL; Michalek J
Laryngoscope; 2016 Jan; 126(1):118-21. PubMed ID: 26467807
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): a 12-year experience in more than 900 patients.
Blitzer A; Brin MF; Stewart CF
Laryngoscope; 1998 Oct; 108(10):1435-41. PubMed ID: 9778279
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin management of adductor spasmodic dysphonia after failed recurrent laryngeal nerve section.
Sulica L; Blitzer A; Brin MF; Stewart CF
Ann Otol Rhinol Laryngol; 2003 Jun; 112(6):499-505. PubMed ID: 12834116
[TBL] [Abstract][Full Text] [Related]
7. Office-based endoscopic botulinum toxin injection in laryngeal movement disorders.
Kaderbay A; Righini CA; Castellanos PF; Atallah I
Eur Ann Otorhinolaryngol Head Neck Dis; 2018 Jun; 135(3):205-207. PubMed ID: 29661610
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin injection in laryngeal dyspnea.
Woisard V; Liu X; Bes MC; Simonetta-Moreau M
Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):909-917. PubMed ID: 27600559
[TBL] [Abstract][Full Text] [Related]
9. Primidone Therapy for Essential Vocal Tremor.
Nida A; Alston J; Schweinfurth J
JAMA Otolaryngol Head Neck Surg; 2016 Feb; 142(2):117-21. PubMed ID: 26660910
[TBL] [Abstract][Full Text] [Related]
10. [Botulinum toxin efficacy in the treatment of patients with spasmodic dysphonia].
Svetel M; Vasić M; Tomić G; Stanković P; Stojanović M; Dragasević N; Dergenc R; Vukasinović M; Pekmezović T; Petrović I; Kostić V
Vojnosanit Pregl; 2007 Oct; 64(10):671-5. PubMed ID: 18041568
[TBL] [Abstract][Full Text] [Related]
11. [Diagnostic and therapeutic difficulties in laryngeal dystonia].
Niebudek-Bogusz E; Modzelewska-Radwan B; Pietruszewska W; Zielińska M; Gryczyński M
Otolaryngol Pol; 2003; 57(5):739-45. PubMed ID: 14994622
[TBL] [Abstract][Full Text] [Related]
12. Botox for hyperadduction of the false vocal folds: a case report.
Rosen CA; Murry T
J Voice; 1999 Jun; 13(2):234-9. PubMed ID: 10442753
[TBL] [Abstract][Full Text] [Related]
13. In-Office Laryngology Injections.
Dion GR; Nielsen SW
Otolaryngol Clin North Am; 2019 Jun; 52(3):521-536. PubMed ID: 30905566
[TBL] [Abstract][Full Text] [Related]
14. Transoral electromyographic recordings in botulinum toxin-injected rat larynges.
Inagi K; Rodriquez AA; Ford CN; Heisey DM
Ann Otol Rhinol Laryngol; 1997 Nov; 106(11):956-64. PubMed ID: 9373087
[TBL] [Abstract][Full Text] [Related]
15. Use of botulinum toxin type A to avoid tracheal intubation or tracheostomy in severe paradoxical vocal cord movement.
Maillard I; Schweizer V; Broccard A; Duscher A; Liaudet L; Schaller MD
Chest; 2000 Sep; 118(3):874-7. PubMed ID: 10988221
[TBL] [Abstract][Full Text] [Related]
16. Life Threatening Delayed Complication of Botulinum Toxin Injection for Treatment of Spasmodic Dysphonia.
Yershov D; Partridge R
Prague Med Rep; 2020; 121(2):114-117. PubMed ID: 32553095
[TBL] [Abstract][Full Text] [Related]
17. Treatment of ventricular dysphonia with botulinum toxin.
Kendall KA; Leonard RJ
Laryngoscope; 1997 Jul; 107(7):948-53. PubMed ID: 9217137
[TBL] [Abstract][Full Text] [Related]
18. Interarytenoid muscle botox injection for treatment of adductor spasmodic dysphonia with vocal tremor.
Kendall KA; Leonard RJ
J Voice; 2011 Jan; 25(1):114-9. PubMed ID: 20137891
[TBL] [Abstract][Full Text] [Related]
19. The effect of botulinum toxin A on the vocal symptoms of spastic dysarthria: a case study.
McHenry M; Whatman J; Pou A
J Voice; 2002 Mar; 16(1):124-31. PubMed ID: 12002879
[TBL] [Abstract][Full Text] [Related]
20. Gender differences in onabotulinum toxin A dosing for adductor spasmodic dysphonia.
Lerner MZ; Lerner BA; Patel AA; Blitzer A
Laryngoscope; 2017 May; 127(5):1131-1134. PubMed ID: 27633917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
